{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:50:34Z","timestamp":1790232634627,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.bone.2013.02.016","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T06:00:47Z","timestamp":1361858447000},"page":"166-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA"],"prefix":"10.1016","volume":"55","author":[{"given":"Anthony J.","family":"Mutsaers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin J.M.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan R.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair M.","family":"Chalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brain J.J.","family":"Liddicoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia W.M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Goradia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. John","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Purton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross A.","family":"Dickins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Walkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.02.016_bb0005","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.ejca.2005.08.026","article-title":"Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27year experience at Rizzoli Institute, Italy","volume":"41","author":"Bacci","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0010","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1002\/cncr.27414","article-title":"Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group","volume":"118","author":"Janeway","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-3329-2-19","article-title":"Genetically engineered mouse models and human osteosarcoma","volume":"2","author":"Ng","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.bone.2013.02.016_bb0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/260436a0","article-title":"Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma","volume":"260","author":"Martin","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.02.016_bb0025","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1172\/JCI42391","article-title":"Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice","volume":"120","author":"Molyneux","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.02.016_bb0030","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1073\/pnas.0805462105","article-title":"Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage","volume":"105","author":"Berman","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.02.016_bb0035","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1101\/gad.1656808","article-title":"Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease","volume":"22","author":"Walkley","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2013.02.016_bb0040","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/carcin\/bgp180","article-title":"Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice","volume":"30","author":"Lin","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bone.2013.02.016_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2011.09.016","article-title":"A blueprint for advancing genetics-based cancer therapy","volume":"147","author":"Sellers","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrc2192","article-title":"Maximizing mouse cancer models","volume":"7","author":"Frese","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ccr.2007.11.012","article-title":"ETV6\u2013NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex","volume":"12","author":"Li","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cell.2011.03.012","article-title":"A rapid and scalable system for studying gene function in mice using conditional RNA interference","volume":"145","author":"Premsrirut","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0065","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ng2045","article-title":"Tissue-specific and reversible RNA interference in transgenic mice","volume":"39","author":"Dickins","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2013.02.016_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1720","article-title":"Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi","volume":"29","author":"Zuber","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bone.2013.02.016_bb0075","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/MCB.23.3.1044-1053.2003","article-title":"Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system","volume":"23","author":"MacPherson","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2013.02.016_bb0080","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.bone.2013.02.016_bb0085","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.016_bb0090","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-11-320564","article-title":"Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment","volume":"117","author":"Singbrant","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bone.2013.02.016_bb0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas","volume":"445","author":"Xue","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.02.016_bb0105","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1084\/jem.20091046","article-title":"Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow","volume":"206","author":"Morikawa","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.bone.2013.02.016_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cell.2011.03.035","article-title":"Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression","volume":"145","author":"Brady","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccr.2012.08.003","article-title":"A \u201ctwist box\u201d code of p53 inactivation: twist box:p53 interaction promotes p53 degradation","volume":"22","author":"Piccinin","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/bbrc.1997.6796","article-title":"CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene","volume":"235","author":"Schroeder","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.02.016_bb0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrc3087","article-title":"Advances in sarcoma genomics and new therapeutic targets","volume":"11","author":"Taylor","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","article-title":"Update on Wnt signaling in bone cell biology and bone disease","volume":"492","author":"Monroe","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bone.2013.02.016_bb0135","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.bjc.6605405","article-title":"Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways","volume":"101","author":"Cleton-Jansen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2013.02.016_bb0145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2012.36","article-title":"Hypoxia-driven pathways in bone development, regeneration and disease","volume":"8","author":"Maes","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bone.2013.02.016_bb0150","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1073\/pnas.0701068104","article-title":"Metagene projection for cross-platform, cross-species characterization of global transcriptional states","volume":"104","author":"Tamayo","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.02.016_bb0155","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2005-6-9-r76","article-title":"A molecular map of mesenchymal tumors","volume":"6","author":"Henderson","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.bone.2013.02.016_bb0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccr.2010.12.023","article-title":"Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma","volume":"19","author":"Rubin","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0165","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/modpathol.3800794","article-title":"Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma","volume":"20","author":"Nakayama","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bone.2013.02.016_bb0170","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/hmg\/ddp057","article-title":"Notch signaling contributes to the pathogenesis of human osteosarcomas","volume":"18","author":"Engin","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bone.2013.02.016_bb0175","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1158\/0008-5472.CAN-08-2929","article-title":"MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression","volume":"69","author":"Ma","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2013.02.016_bb0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2007.01.016","article-title":"A conditional mouse model of synovial sarcoma: insights into a myogenic origin","volume":"11","author":"Haldar","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200507106","article-title":"p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling","volume":"172","author":"Wang","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2013.02.016_bb0190","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature09781","article-title":"Cells of origin in cancer","volume":"469","author":"Visvader","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.02.016_bb0195","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-10-2282","article-title":"PDK1 attenuation fails to prevent tumor formation in PTEN-deficient transgenic mouse models","volume":"71","author":"Ellwood-Yen","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2013.02.016_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1677\/JME-09-0030","article-title":"Transgenic mice expressing small interfering RNA against Gata4 point to a crucial role of Gata4 in the heart and gonads","volume":"43","author":"Thurisch","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.bone.2013.02.016_bb0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ng.556","article-title":"Subtle variations in Pten dose determine cancer susceptibility","volume":"42","author":"Alimonti","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2013.02.016_bb0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/0008-5472.CAN-10-2488","article-title":"PTEN level in tumor suppression: how much is too little?","volume":"71","author":"Carracedo","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2013.02.016_bb0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/gcc.10132","article-title":"Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas","volume":"36","author":"Bayani","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0220","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/gcc.21956","article-title":"Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data","volume":"51","author":"Kuijjer","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0225","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ijc.24392","article-title":"Gene expression profiling of alpha-radiation-induced rat osteosarcomas: identification of dysregulated genes involved in radiation-induced tumorigenesis of bone","volume":"125","author":"Daino","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bone.2013.02.016_bb0230","doi-asserted-by":"crossref","first-page":"14117","DOI":"10.1074\/jbc.M808337200","article-title":"Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2","volume":"284","author":"Friedman","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.02.016_bb0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","article-title":"Reversible tumorigenesis by MYC in hematopoietic lineages","volume":"4","author":"Felsher","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.bone.2013.02.016_bb0240","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/onc.2010.312","article-title":"c-MYC overexpression with loss of Ink4a\/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis","volume":"29","author":"Shimizu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2013.02.016_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.02.016_bb0250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/15321819.2010.538110","article-title":"The presence of TRAIL\u2013OPG complex in human osteosarcoma and human salivary gland adenocarcinoma","volume":"32","author":"Mogi","year":"2011","journal-title":"J Immunoassay Immunochem"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T12:26:00Z","timestamp":1539865560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328213000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S8756328213000872"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.02.016","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}